Consistent with the results from diabetic nephropathy, obese, diabetic, hypertensive ZSF1 rats treated with tempol showed increased SOD activity and significantly reduced lipid peroxidation and peroxidase activity in the kidney [148]. Here, SOD1 is linked to diabetic kidney disease.